Toole : We have to start the conversation with ourselves
However, if the molecule targets different cells, a toxic effect could be observed
After at least two years of treatment, GLP-1 users had a 37 percent higher chance of developing alopecia than patients taking SGLT-2 drugs and 68 percent higher odds than those taking DPP-4 drugs, both of which are also used to treat type 2 diabetes
Needles longer than 8mm increase the risk of reaching muscle, especially in leaner individuals and at injection sites with thinner subcutaneous fat
Patient assistance programs provide free medication to qualifying low-income uninsured patients, but strict income cutoffs exclude many people who earn too much to qualify yet not enough to afford $900+ monthly medication costs
As someone passionate about pharmaceutical innovation and regulatory science, I'm eager to see how this advancement will improve patient access and outcomes in chronic disease management